TherapeuticsMD Inc. share price logo

TherapeuticsMD Inc.

NASDAQ: TXMD

$2.04

+0.01

(+0.50%)

as on

TherapeuticsMD Inc. Stock Performance

as on August 4, 2026 at 6:33 am IST

  • Day's Low

    Day's High

    $2.02
    $2.08
    downward going graph

    0.98%

    Downside

    1.96%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.99
    $2.95
    downward going graph

    51.47%

    Downside

    44.61%

    Upside

    downward going graph

TherapeuticsMD Inc. share price movements today

Previous Close
$2.03
Open
$2.02
Volume
90.4K
Day's Low - High
$2.02 - $2.08
52 Week Low - High
$0.99 - $2.95

TherapeuticsMD Inc. Historical Returns

1 Month Return
-3.79 %
3 Month Return
+ 0.5 %
1 Year Return
+ 84.55 %
3 Year Return
-52.35 %
5 Year Return
-95.56 %

TherapeuticsMD Inc. Stock Fundamentals & Key Indicators

Check TherapeuticsMD Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.5M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

203

Industry PE ratio

-0.9844444444444445

PEG Ratio

-0.73

EBITDA

-1.4M

Revenue (TTM)

3.4M

Profit Margin

5.34%

Return On Equity TTM

0.32%

TherapeuticsMD Inc. Stock Valuation

Track how TherapeuticsMD Inc. P/E has moved over time to understand its valuation trends.

TherapeuticsMD Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-9.62x)

March 31, 2025

Industry (-0.98x)

August 4, 2026

Today (203.00x)

August 4, 2026

Highest (44.97x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 203.00x

TherapeuticsMD Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of TherapeuticsMD Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
TherapeuticsMD Inc. image
TherapeuticsMD Inc.
SELL$23.5M-95.56%2035.34%NA
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$25.8B151.21%19.1240.62%NA
Viatris Inc. image
Viatris Inc.
HOLD$20.4B27.62%NA-2.04%2.7%
Haleon plc (ADR) image
Haleon plc (ADR)
BUY$43.5BNA20.5614.55%1.96%
ZOETIS INC. image
ZOETIS INC.
BUY$31.9B-62.26%12.6728.04%2.67%
See all

Stock Returns calculator for TherapeuticsMD Inc. Stock including INR - Dollar returns

The TherapeuticsMD Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

TherapeuticsMD Inc. investment value today

Current value as on today

₹2,01,646

Returns

₹1,01,646

(+101.65%)

Returns from TherapeuticsMD Inc. Stock

₹85,455 (+85.45%)

Dollar Impact

₹16,191 (+16.19%)

Analyst Recommendation on TherapeuticsMD Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for TherapeuticsMD Inc.. Average target price of $5

TherapeuticsMD Inc. Share Price Target

Get share price movements and forecasts by analysts on TherapeuticsMD Inc..

What analysts predicted

59.2%UPSIDE

Target Price

$5

Current Price

$2.04

Analyzed by

6 Analysts

Target

$5.00

TherapeuticsMD Inc. target price $5, a slight upside of 59.2% compared to current price of $2.04. According to 6 analysts rating.

Indian Investors' Interest in TherapeuticsMD Inc. Stock

Search interest for TherapeuticsMD Inc. Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-53% versus previous 30 day period

TherapeuticsMD Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-1
-2
0
0
-1
0
0
-1
0
EBITDA
0
-1
0
0
0
-1
0
0
-3
0
Interest Expense
0
0
0
0
-
0
0
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
0
-1
0
0
0
0
0
0
0
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
0
0
-1
0
0
0
0
0
0
0
Net Profit Margin
-175.90%
-234.50%
-465.81%
-111.33%
37.78%
-166.16%
57.88%
19.39%
-69.32%
13.12%

TherapeuticsMD Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
19
16
16
49
64
2
69
1
1
3
Gross Profit
15
14
13
43
48
1
68
1
1
1
Operating Income
-90
-77
-130
-151
-155
-79
1
-8
-4
-4
EBITDA
-89
-76
-127
-158
-153
-70
11
-8
-2
-3
Interest Expense
-
-
4
17
28
32
12
0
0
0
Depreciation
-
0
0
1
4
4
1
0
0
1
Income Before Tax
-89
-76
-132
-176
-183
-79
1
-7
-2
0
Income Tax Expense
0
0
2
19
29
33
-91
0
0
0
Net Income
-89
-76
-132
-176
-183
-172
111
-10
-2
0
Net Profit Margin
-464.32%
-458.50%
-823.74%
-354.79%
-282.90%
-6700.93%
160.08%
-789.40%
-123.85%
-18.83%

TherapeuticsMD Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
0
-1
0
0
0
0
0
0
0
Operating Cash Flow
0
0
0
0
0
0
1
0
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
2
-
-
-
-
-
-
-
-
Change in Cash
0
0
0
0
0
0
1
0
0

TherapeuticsMD Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-76
-132
-176
-183
-79
1
-7
-2
0
Operating Cash Flow
-76
-106
-165
-159
-147
-4
-48
0
2
Investing Cash Flow
0
-21
-23
-1
-2
223
-
-
-
Financing Cash Flow
72
162
188
80
134
-235
3
-
-
Change in Cash
-4
34
0
-80
-15
-15
-44
0
2

Global Institutional Holdings in TherapeuticsMD Inc.

Funds
Holdings
Susquehanna International Group, LLP
0.18%
J. Goldman & Co LP
0.12%
Squadron Capital Management LLC
3.63%
JPMorgan Chase & Co
0%
BlackRock Inc
0.99%
See all

Insights on TherapeuticsMD Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, TXMD stock has moved up by 82.9%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -619.0K → 95.0K (in $), with an average increase of 751.6% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 99.3% return, outperforming this stock by 16.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 68.0% return, outperforming this stock by 119.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 893.0K → 724.0K (in $), with an average decrease of 18.9% per quarter

About TherapeuticsMD Inc.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
OrganisationTherapeuticsMD Inc.
Headquarters951 Yamato Road, Boca Raton, FL, United States, 33431
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Marlan D. Walker J.D.
E-voting on sharesClick here to vote

Key Management of TherapeuticsMD Inc.

Name

Title

Mr. Marlan D. Walker J.D.

Chief Executive Officer

Mr. Joseph A. Ziegler

Principal Financial & Accounting Officer

FAQs

What is TherapeuticsMD Inc. share price today?

TherapeuticsMD Inc. share price today is $2.04 as on at the close of the market. TherapeuticsMD Inc. share today touched a day high of $2.08 and a low of $2.02.

What is the 52 week high and 52 week low for TherapeuticsMD Inc. share?

TherapeuticsMD Inc. share touched a 52 week high of $2.95 on and a 52 week low of $0.99 on . TherapeuticsMD Inc. stock price today i.e. is closed at $2.04,which is 30.85% down from its 52 week high and 106.06% up from its 52 week low.

What is TherapeuticsMD Inc.'s market capitalisation today?

TherapeuticsMD Inc. market capitalisation is $0.00T as on .

How to invest in TherapeuticsMD Inc. Stock (TXMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for TherapeuticsMD Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in TherapeuticsMD Inc. Shares that will get you 0.7353 shares as per TherapeuticsMD Inc. share price of $2.04 per share as on August 4, 2026 at 1:03 am IST.

What is the minimum amount required to buy TherapeuticsMD Inc. Stock (TXMD) from India?

Indian investors can start investing in TherapeuticsMD Inc. (TXMD) shares with as little as ₹95.335 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.35 in TherapeuticsMD Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on TherapeuticsMD Inc. share’s latest price of $2.04 as on August 4, 2026 at 1:03 am IST, you will get 4.9020 shares of TherapeuticsMD Inc.. Learn more about fractional shares .

What are the returns that TherapeuticsMD Inc. has given to Indian investors in the last 5 years?

TherapeuticsMD Inc. stock has given -95.56% share price returns and 28.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?